Tumor Ablation Market

Tumor Ablation Market (Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, High-intensity Focused Ultrasound, Laser Interstitial Thermal Ablation, and Others) - Global Industry Analysis, Size, Share: Growth, Trends, and Forecast, 2023-2031

Tumor Ablation Market Outlook 2031

  • The global industry was valued at US$ 1.3 Bn in 2022
  • It is estimated to grow at a CAGR of 6.9% from 2023 to 2031 and reach US$ 2.3 Bn by the end of 2031

Analyst Viewpoint

Rise in prevalence of cancer is boosting the tumor ablation market size. Increase in awareness about cancer care is further fueling the demand for tumor ablation procedures. Radiofrequency ablation is gaining popularity as a critical cancer care technique for survival and pain management of patients.

Enhanced patient comfort, faster recovery time, and reduced procedure time are a few positive reasons why ablation therapy is gaining traction in the market. Prominent vendors operating in the global tumor ablation sector are investing significantly in R&D activities and partnerships to expand their product portfolio. Technological advancements in terms of improved accuracy, portability, and cost-effectiveness are likely to foster tumor ablation industry growth.

Tumor Ablation Market

Market Introduction

Tumor ablation is an image-guided, minimally intrusive surgery that aims to destroy cancer cells by exposure to either very cold or very hot temperatures. Ablation therapy is employed to treat cancer at its very source and also at a place where it metastasizes. According to World Health Organization (WHO), about 10-11 million people worldwide are expected to be diagnosed each year with cancer till 2030.

Tumor ablation utilizes advanced techniques such as radiofrequency, microwave ablation, and cryoablation to precisely act on the cancerous tissue while avoiding healthy tissue. Rise in global geriatric population and awareness of available cancer care are likely to propel market progress of the tumor ablation industry.

Liver cancer is the dominant segment of the tumor ablation industry based on disease indication. Lung cancer is also on the rise as air pollution worsens and the effects of long-term tobacco use become visible in older users.

Rise in Prevalence of Cancer Fueling Tumor Ablation Market Growth

Cancer is a globally prevalent disease and a leading cause of death worldwide. According to data publicly available by WHO, the disease accounts for nearly one in six deaths. WHO further mentions that cancer-causing infections such as hepatitis made up nearly one-third of cancer cases in the global South. A drastic increase in the global geriatric population and unhealthy modern lifestyles across age groups has worsened the prevalence of cancer.

Increase in expenditure on cancer care is augmenting the tumor ablation market revenue. In the U.S., National Cancer Institute forecasted that national estimates of cancer care costs are expected to rise to as high as US$ 173 Bn in 2020. Radiofrequency ablation technique is employed to treat tumors during early phase of their existence, which is critical for a patient’s survival and pain management.

High Demand for Minimally Invasive Therapies Driving Tumor Ablation Market Demand

Minimally invasive surgeries or therapies are hugely popular both with doctors and patients due to advantages such as faster recovery, enhanced patient comfort, and reduced procedure time. The ablative therapy industry post-pandemic has witnessed a surge in market statistics as awareness of healthcare products and services has increased.

Ablative therapies are employed primarily for smaller tumors, where precision is required. Advancement in tumor ablation devices and techniques such as utilization of image-guided equipment, internally cooled radiofrequency probes, and cryoablation are expected to offer lucrative opportunities for market expansion.

Regional Outlook

North America accounted for dominant tumor ablation market share in 2022. Presence of a well-developed healthcare sector, rise in awareness about upcoming cancer care technologies, and R&D of new care solutions are augmenting the market dynamics of the region.

According to the latest tumor ablation industry analysis, Europe is a lucrative market due to the availability of public healthcare and implementation of strict government laws regarding caregiving.

The tumor ablation market value is surging in developing countries such as China and India due to the strong presence of healthcare providers. Cancer welfare initiatives in the Asia Pacific region such as the Indian Government’s Health Minister’s Cancer Patient Fund (HMCPF) offers financial aid to patients in need. Efforts such as these are expected to foster a surge in usage of tumor ablation devices.

Analysis of Key Players

According to recent tumor ablation market trends, prominent manufacturers are investing substantially in the development of next-gen cancer therapy technologies. Close collaborations within the industry along with mergers and acquisitions are seen as key strategies to build a better product portfolio and maintain a strong position in the sector.

For example, in July 2021, Terumo Europe and University Medical Center Utrecht (UMC Utrecht) signed a Memorandum of Understanding (MoU) to collaborate on product development and technology transfer in the field of oncology. The move is expected to bring further developments to tumor ablation products in the near future.

Medtronic PLC, Integra LifeSciences Holdings Corpo. , BTG International Ltd, Boston Scientific Corporation, AngioDynamics Inc., SonaCare Medical LLC., BVM Medical Limited, St. Jude Medical, Inc., and EDAP TMS S.A. are key firms operating in this market.

These companies have been profiled in the tumor ablation market report based on various parameters such as company overview, business strategies, product portfolio, financial overview, and business segments.

Key Developments

  • In July 2023, Compal Electronics, a Taiwanese electronics company announced a novel radiofrequency ablation system. This marks the company’s expansion into the ablative cancer treatment market.
  • In February 2023, an American woman was treated for breast cancer fully by non-invasive ablation therapy in a first-of-its kind clinical trial. The technology was developed at Huntsman Cancer Institute in collaboration with University of Utah.

Tumor Ablation Market Snapshot

Attribute Detail
Market Value in 2022 (Base Year) US$ 1.3 Bn
Market Forecast Value in 2031 US$ 2.3 Bn
Growth Rate (CAGR) 6.9%
Forecast Period 2023 to 2031
Historical Data Available for 2021
Quantitative Units US$ Bn for Value
Market Analysis Qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the regional level, the qualitative analysis includes key trends, price trends, and key supplier analysis.
Competition Landscape
  • Prominent Players – Competition Dashboard and Revenue Share Analysis, 2022
  • Company Profiles (Details – Company Overview, Sales Area/Geographical Presence, Revenue, Strategy & Business Overview)
Format Electronic (PDF) + Excel
Market Segmentation
  • Technology
    • Radiofrequency Ablation
    • Microwave Ablation
    • Cryoablation
    • High-intensity Focused Ultrasound
    • Laser Interstitial Thermal Ablation
    • Others
  • Disease Indication
    • Liver Cancer
    • Lung Cancer
    • Kidney Cancer
    • Bone Cancer
    • Breast Cancer
    • Prostate Cancer
    • Others
  • End-user
    • Home Users
    • Clinics
    • Hospitals
Regions Covered
  • North America
  • Latin America
  • Asia Pacific
  • Europe
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Russia and CIS
  • Japan
  • China
  • India
  • ASEAN
  • Brazil
  • Mexico
  • GCC
  • South Africa
Companies Profiled
  • Medtronic PLC
  • Integra LifeSciences Holdings Corporation
  • BTG International Ltd
  • Boston Scientific Corporation
  • AngioDynamics Inc.
  • SonaCare Medical LLC.
  • BVM Medical Limited
  • St. Jude Medical, Inc.
  • EDAP TMS S.A.
Customization Scope Available upon Request
Pricing Available upon Request

Frequently Asked Questions

How big was the global tumor ablation market in 2022?

It was valued at US$ 1.3 Bn in 2022

How is the tumor ablation business expected to grow during the forecast period?

It is projected to grow at a CAGR of 6.9% from 2023 to 2031

What are the key factors driving the demand for tumor ablation therapy?

Rise in prevalence of cancer and high demand for minimally invasive therapies

Which tumor ablation technology segment held the largest share in 2022?

The radiofrequency ablation segment held the largest share in 2022

Which was the major region in the global tumor ablation industry in 2022?

North America dominated the global landscape in 2022

Who are the key tumor ablation manufacturers?

Medtronic PLC, Integra LifeSciences Holdings Corporation , BTG International Ltd, Boston Scientific Corporation, AngioDynamics Inc., SonaCare Medical LLC., BVM Medical Limited, St. Jude Medical, Inc., and EDAP TMS S.A

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Tumor Ablation Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Technology, Definition

            4.1.2. Industry Evolution/Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Tumor Ablation Market Analysis and Forecast, 2023–2031

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. Key Technology, /Brand Analysis

        5.3. Key Mergers & Acquisitions

        5.4. COVID-19 Pandemic Impact on Industry

    6. Tumor Ablation Market Analysis and Forecast, by Technology,

        6.1. Introduction & Definition

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Technology, 2023–2031

            6.3.1. Radiofrequency Ablation

            6.3.2. Microwave Ablation

            6.3.3. Cryoablation

            6.3.4. High-Intensity Focused Ultrasound

            6.3.5. Laser Interstitial Thermal Ablation

            6.3.6. Others

        6.4. Market Attractiveness Analysis, by Technology,

    7. Tumor Ablation Market Analysis and Forecast, by Disease Indication

        7.1. Introduction & Definition

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Disease Indication, 2023–2031

            7.3.1. Liver Cancer

            7.3.2. Lung Cancer

            7.3.3. Kidney Cancer

            7.3.4. Bone Cancer

            7.3.5. Breast Cancer

            7.3.6. Prostate Cancer

            7.3.7. Others

        7.4. Market Attractiveness Analysis, by Disease Indication

    8. Tumor Ablation Market Analysis and Forecast, by End-user

        8.1. Introduction & Definition

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, by End-user, 2023–2031

            8.3.1. Home users

            8.3.2. Clinics

            8.3.3. Hospitals

        8.4. Market Attractiveness Analysis, by Disease Indication

    9. Tumor Ablation Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region, 2023–2031

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness Analysis, by Region

    10. North America Tumor Ablation Market Analysis and Forecast

        10.1. Introduction

        10.2. Key Findings

        10.3. Market Value Forecast, by Technology, 2023–2031

            10.3.1. Radiofrequency Ablation

            10.3.2. Microwave Ablation

            10.3.3. Cryoablation

            10.3.4. High-Intensity Focused Ultrasound

            10.3.5. Laser Interstitial Thermal Ablation

            10.3.6. Others

        10.4. Market Value Forecast, by Disease Indication, 2023–2031

            10.4.1. Liver Cancer

            10.4.2. Lung Cancer

            10.4.3. Kidney Cancer

            10.4.4. Bone Cancer

            10.4.5. Breast Cancer

            10.4.6. Prostate Cancer

            10.4.7. Others

        10.5. Market Value Forecast, by End-user, 2023–2031

            10.5.1. Home users

            10.5.2. Clinics

            10.5.3. Hospitals

        10.6. Market Value Forecast, by Country, 2023–2031

            10.6.1. U.S.

            10.6.2. Canada

        10.7. Market Attractiveness Analysis

            10.7.1. By Technology,

            10.7.2. By Disease Indication

            10.7.3. By End-user

            10.7.4. By Country

    11. Europe Tumor Ablation Market Analysis and Forecast

        11.1. Introduction

        11.2. Key Findings

        11.3. Market Value Forecast, by Technology, 2023–2031

            11.3.1. Radiofrequency Ablation

            11.3.2. Microwave Ablation

            11.3.3. Cryoablation

            11.3.4. High-Intensity Focused Ultrasound

            11.3.5. Laser Interstitial Thermal Ablation

            11.3.6. Others

        11.4. Market Value Forecast, by Disease Indication, 2023–2031

            11.4.1. Liver Cancer

            11.4.2. Lung Cancer

            11.4.3. Kidney Cancer

            11.4.4. Bone Cancer

            11.4.5. Breast Cancer

            11.4.6. Prostate Cancer

            11.4.7. Others

        11.5. Market Value Forecast, by End-user, 2023–2031

            11.5.1. Home users

            11.5.2. Clinics

            11.5.3. Hospitals

        11.6. Market Value Forecast, by Country/Sub-region, 2023–2031

            11.6.1. Germany

            11.6.2. U.K.

            11.6.3. France

            11.6.4. Italy

            11.6.5. Spain

            11.6.6. Rest of Europe

        11.7. Market Attractiveness Analysis

            11.7.1. By Technology,

            11.7.2. By Disease Indication

            11.7.3. By End-user

            11.7.4. By Country/Sub-region

    12. Asia Pacific Tumor Ablation Market Analysis and Forecast

        12.1. Introduction

        12.2. Key Findings

        12.3. Market Value Forecast, by Technology, 2023–2031

            12.3.1. Radiofrequency Ablation

            12.3.2. Microwave Ablation

            12.3.3. Cryoablation

            12.3.4. High-Intensity Focused Ultrasound

            12.3.5. Laser Interstitial Thermal Ablation

            12.3.6. Others

        12.4. Market Value Forecast, by Disease Indication, 2023–2031

            12.4.1. Liver Cancer

            12.4.2. Lung Cancer

            12.4.3. Kidney Cancer

            12.4.4. Bone Cancer

            12.4.5. Breast Cancer

            12.4.6. Prostate Cancer

            12.4.7. Others

        12.5. Market Value Forecast, by End-user, 2023–2031

            12.5.1. Home users

            12.5.2. Clinics

            12.5.3. Hospitals

        12.6. Market Value Forecast, by Country/Sub-region, 2023–2031

            12.6.1. China

            12.6.2. Japan

            12.6.3. India

            12.6.4. Australia & New Zealand

            12.6.5. Rest of Asia Pacific

        12.7. Market Attractiveness Analysis

            12.7.1. By Technology,

            12.7.2. By Disease Indication

            12.7.3. By End-user

            12.7.4. By Country/Sub-region

    13. Latin America Tumor Ablation Market Analysis and Forecast

        13.1. Introduction

        13.2. Key Findings

        13.3. Market Value Forecast, by Technology, 2023–2031

            13.3.1. Radiofrequency Ablation

            13.3.2. Microwave Ablation

            13.3.3. Cryoablation

            13.3.4. High-Intensity Focused Ultrasound

            13.3.5. Laser Interstitial Thermal Ablation

            13.3.6. Others

        13.4. Market Value Forecast, by Disease Indication, 2023–2031

            13.4.1. Liver Cancer

            13.4.2. Lung Cancer

            13.4.3. Kidney Cancer

            13.4.4. Bone Cancer

            13.4.5. Breast Cancer

            13.4.6. Prostate Cancer

            13.4.7. Others

        13.5. Market Value Forecast, by End-user, 2023–2031

            13.5.1. Home users

            13.5.2. Clinics

            13.5.3. Hospitals

        13.6. Market Value Forecast, by Country/Sub-region, 2023–2031

            13.6.1. Brazil

            13.6.2. Mexico

            13.6.3. Rest of Latin America

        13.7. Market Attractiveness Analysis

            13.7.1. By Technology,

            13.7.2. By Disease Indication

            13.7.3. By End-user

            13.7.4. By Country/Sub-region

    14. Middle East & Africa Tumor Ablation Market Analysis and Forecast

        14.1. Introduction

        14.2. Key Findings

        14.3. Market Value Forecast, by Technology, 2023–2031

            14.3.1. Radiofrequency Ablation

            14.3.2. Microwave Ablation

            14.3.3. Cryoablation

            14.3.4. High-Intensity Focused Ultrasound

            14.3.5. Laser Interstitial Thermal Ablation

            14.3.6. Others

        14.4. Market Value Forecast, by Disease Indication, 2023–2031

            14.4.1. Liver Cancer

            14.4.2. Lung Cancer

            14.4.3. Kidney Cancer

            14.4.4. Bone Cancer

            14.4.5. Breast Cancer

            14.4.6. Prostate Cancer

            14.4.7. Others

        14.5. Market Value Forecast, by End-user, 2023–2031

            14.5.1. Home users

            14.5.2. Clinics

            14.5.3. Hospitals

        14.6. Market Value Forecast, by Country/Sub-region, 2023–2031

            14.6.1. GCC Countries

            14.6.2. South Africa

            14.6.3. Rest of Middle East & Africa

        14.7. Market Attractiveness Analysis

            14.7.1. By Technology,

            14.7.2. By Disease Indication

            14.7.3. By End-user

            14.7.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)

        15.2. Market Share Analysis, by Company (2022)

        15.3. Company Profiles

            15.3.1. Medtronic PLC

                15.3.1.1. Company Overview

                15.3.1.2. Technology, Portfolio

                15.3.1.3. SWOT Analysis

                15.3.1.4. Financial Overview

                15.3.1.5. Strategic Overview

            15.3.2. Integra LifeSciences Holdings Corporation

                15.3.2.1. Company Overview

                15.3.2.2. Technology, Portfolio

                15.3.2.3. SWOT Analysis

                15.3.2.4. Financial Overview

                15.3.2.5. Strategic Overview

            15.3.3. BTG International Ltd.

                15.3.3.1. Company Overview

                15.3.3.2. Technology, Portfolio

                15.3.3.3. SWOT Analysis

                15.3.3.4. Financial Overview

                15.3.3.5. Strategic Overview

            15.3.4. Boston Scientific Corporation

                15.3.4.1. Company Overview

                15.3.4.2. Technology, Portfolio

                15.3.4.3. SWOT Analysis

                15.3.4.4. Financial Overview

                15.3.4.5. Strategic Overview

            15.3.5. AngioDynamics Inc.

                15.3.5.1. Company Overview

                15.3.5.2. Technology, Portfolio

                15.3.5.3. SWOT Analysis

                15.3.5.4. Financial Overview

                15.3.5.5. Strategic Overview

            15.3.6. SonaCare Medical LLC.

                15.3.6.1. Company Overview

                15.3.6.2. Technology, Portfolio

                15.3.6.3. SWOT Analysis

                15.3.6.4. Financial Overview

                15.3.6.5. Strategic Overview

            15.3.7. BVM Medical Limited

                15.3.7.1. Company Overview

                15.3.7.2. Technology, Portfolio

                15.3.7.3. SWOT Analysis

                15.3.7.4. Financial Overview

                15.3.7.5. Strategic Overview

            15.3.8. St. Jude Medical, Inc.

                15.3.8.1. Company Overview

                15.3.8.2. Technology, Portfolio

                15.3.8.3. SWOT Analysis

                15.3.8.4. Financial Overview

                15.3.8.5. Strategic Overview

            15.3.9. EDAP TMS S.A

                15.3.9.1. Company Overview

                15.3.9.2. Technology, Portfolio

                15.3.9.3. SWOT Analysis

                15.3.9.4. Financial Overview

                15.3.9.5. Strategic Overview

    List of Tables

    Table 01: Tumor Ablation Market Size (US$ Mn) Forecast, by Technology, 2023–2031

    Table 02: Tumor Ablation Market Size (US$ Mn) Forecast, by Disease Indication, 2023–2031

    Table 03: Tumor Ablation Market Size (US$ Mn) Forecast, by End-user, 2023–2031

    Table 04: Tumor Ablation Market Size (US$ Mn) Forecast, by Region, 2023–2031

    Table 05: North America Tumor Ablation Market Size (US$ Mn) Forecast, by Country, 2023–2031

    Table 06: North America Tumor Ablation Market Size (US$ Mn) Forecast, by Technology, 2023–2031

    Table 07: North America Tumor Ablation Market Size (US$ Mn) Forecast, by Disease Indication, 2023–2031

    Table 08: North America Tumor Ablation Market Size (US$ Mn) Forecast, by End-user, 2023–2031

    Table 09: Europe Tumor Ablation Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2031

    Table 10: Europe Tumor Ablation Market Size (US$ Mn) Forecast, by Technology, 2023–2031

    Table 11: Europe Tumor Ablation Market Size (US$ Mn) Forecast, by Disease Indication, 2023–2031

    Table 12: Europe Tumor Ablation Market Size (US$ Mn) Forecast, by End-user, 2023–2031

    Table 13: Asia Pacific Tumor Ablation Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2031

    Table 14: Asia Pacific Tumor Ablation Market Size (US$ Mn) Forecast, by Technology, 2023–2031

    Table 15: Asia Pacific Tumor Ablation Market Size (US$ Mn) Forecast, by Disease Indication, 2023–2031

    Table 16: Asia Pacific Tumor Ablation Market Size (US$ Mn) Forecast, by End-user, 2023–2031

    Table 17: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2031

    Table 18: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, by Technology, 2023–2031

    Table 19: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, by Disease Indication, 2023–2031

    Table 20: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, by End-user, 2023–2031

    Table 21: Middle East & Africa Tumor Ablation Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2031

    Table 22: Middle East & Africa Tumor Ablation Market Size (US$ Mn) Forecast, by Technology, 2023–2031

    Table 23: Middle East & Africa Tumor Ablation Market Size (US$ Mn) Forecast, by Disease Indication, 2023–2031

    Table 24: Middle East & Africa Tumor Ablation Market Size (US$ Mn) Forecast, by End-user, 2023–2031

    List of Figures

    Figure 01: Tumor Ablation Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2031

    Figure 02: Tumor Ablation Market Revenue (US$ Mn), by Technology, 2022

    Figure 03: Tumor Ablation Market Value Share, by Technology, 2022

    Figure 04: Tumor Ablation Market Revenue (US$ Mn), by Disease Indication, 2022

    Figure 05: Tumor Ablation Market Value Share, by Disease Indication, 2022

    Figure 06: Tumor Ablation Market Revenue (US$ Mn), by End-user, 2022

    Figure 07: Tumor Ablation Market Value Share, by End-user, 2022

    Figure 08: Tumor Ablation Market Value Share, by Region, 2022

    Figure 09: Tumor Ablation Market Value (US$ Mn) Forecast, 2023–2031

    Figure 10: Tumor Ablation Market Value Share Analysis, by Technology, 2023 and 2031

    Figure 11: Tumor Ablation Market Attractiveness Analysis, by Technology, 2023-2031

    Figure 12: Tumor Ablation Market Value Share Analysis, by Disease Indication, 2023 and 2031

    Figure 13: Tumor Ablation Market Attractiveness Analysis, by Disease Indication, 2023-2031

    Figure 14: Tumor Ablation Market Value Share Analysis, by End-user, 2023 and 2031

    Figure 15: Tumor Ablation Market Attractiveness Analysis, by End-user, 2023-2031

    Figure 16: Tumor Ablation Market Value Share Analysis, by Region, 2023 and 2031

    Figure 17: Tumor Ablation Market Attractiveness Analysis, by Region, 2023-2031

    Figure 18: North America Tumor Ablation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

    Figure 19: North America Tumor Ablation Market Attractiveness Analysis, by Country, 2023–2031

    Figure 20: North America Tumor Ablation Market Value Share Analysis, by Country, 2023 and 2031

    Figure 21: North America Tumor Ablation Market Value Share Analysis, by Technology, 2023 and 2031

    Figure 22: North America Tumor Ablation Market Value Share Analysis, by Disease Indication, 2023 and 2031

    Figure 23: North America Tumor Ablation Market Value Share Analysis, by End-user, 2023 and 2031

    Figure 24: North America Tumor Ablation Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 25: North America Tumor Ablation Market Attractiveness Analysis, by Disease Indication, 2023–2031

    Figure 26:North America Tumor Ablation Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 27: Europe Tumor Ablation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

    Figure 28: Europe Tumor Ablation Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 29: Europe Tumor Ablation Market Value Share Analysis, by Country/Sub-region, 2023 and 2031

    Figure 30: Europe Tumor Ablation Market Value Share Analysis, by Technology, 2023 and 2031

    Figure 31: Europe Tumor Ablation Market Value Share Analysis, by Disease Indication, 2023 and 2031

    Figure 32: Europe Tumor Ablation Market Value Share Analysis, by End-user, 2023 and 2031

    Figure 33: Europe Tumor Ablation Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 34: Europe Tumor Ablation Market Attractiveness Analysis, by Disease Indication, 2023–2031

    Figure 35: Europe Tumor Ablation Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 36: Asia Pacific Tumor Ablation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

    Figure 37: Asia Pacific Tumor Ablation Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 38: Asia Pacific Tumor Ablation Market Value Share Analysis, by Country/Sub-region, 2023 and 2031

    Figure 39: Asia Pacific Tumor Ablation Market Value Share Analysis, by Technology, 2023 and 2031

    Figure 40: Asia Pacific Tumor Ablation Market Value Share Analysis, by Disease Indication, 2023 and 2031

    Figure 41: Asia Pacific Tumor Ablation Market Value Share Analysis, by End-user, 2023 and 2031

    Figure 42: Asia Pacific Tumor Ablation Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 43: Asia Pacific Tumor Ablation Market Attractiveness Analysis, by Disease Indication, 2023–2031

    Figure 44: Asia Pacific Tumor Ablation Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 45: Latin America Tumor Ablation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

    Figure 46: Latin America Tumor Ablation Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 47: Latin America Tumor Ablation Market Value Share Analysis, by Country/Sub-region, 2023 and 2031

    Figure 48: Latin America Tumor Ablation Market Value Share Analysis, by Technology, 2023 and 2031

    Figure 49: Latin America Tumor Ablation Market Value Share Analysis, by Disease Indication, 2023 and 2031

    Figure 50: Latin America Tumor Ablation Market Value Share Analysis, by End-user, 2023 and 2031

    Figure 51: Latin America Tumor Ablation Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 52: Latin America Tumor Ablation Market Attractiveness Analysis, by Disease Indication, 2023–2031

    Figure 53: Latin America Tumor Ablation Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 54: Middle East & Africa Tumor Ablation Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

    Figure 55: Middle East & Africa Tumor Ablation Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 56: Middle East & Africa Tumor Ablation Market Value Share Analysis, by Country/Sub-region, 2023 and 2031

    Figure 57: Middle East & Africa Tumor Ablation Market Value Share Analysis, by Technology, 2023 and 2031

    Figure 58: Middle East & Africa Tumor Ablation Market Value Share Analysis, by Disease Indication, 2023 and 2031

    Figure 59: Middle East & Africa Tumor Ablation Market Value Share Analysis, by End-user, 2023 and 2031

    Figure 60: Middle East & Africa Tumor Ablation Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 61: Middle East & Africa Tumor Ablation Market Attractiveness Analysis, by Disease Indication, 2023–2031

    Figure 62: Middle East & Africa Tumor Ablation Market Attractiveness Analysis, by End-user, 2023–2031

Copyright © Transparency Market Research, Inc. All Rights reserved